We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sandro Pignata

Sandro Pignata MD

Director, Uro-Gynecological Department, National Cancer Institute “G. Pascale” Foundation, Naples, Italy; Founder and President, MITO Group (Multicenter Italian Trial in Ovarian Cancer and Gynaecologic Malignancies)

Sandro Pignata was born in 1962 in Naples, Italy. He received his M.D. Degree in 1986 at the University Federico II of Naples, and subsequently the specialty in Oncology at the same University. Dr. Pignata is Director of the Uro-Gynecological Department of the National Cancer Institute “G.Pascale” Foundation, Napoli, Italy. Dr. Pignata is member of the Italian Association of Medical Oncology (AIOM) and of the EORTC Gynecologic Group. Dr. Pignata is the founder and current president of the MITO group (Multicenter Italian Trial in Ovarian cancer and gynaecologic malignancies), which includes about 80 Italian centers involved in the care of gynaecologic cancers. Since 2005, the MITO group is associated to the GCIG (Gynecological Cancer InterGroup), and dr Pignata is member of the GCIG executive board. As president of the MITO group, dr. Pignata is the coordinator of several trials in gynaecologic oncology, some of which have been recently published in international journals. He is author of many scientific papers and has presented the results of his research in many Italian and international oncology meetings.